2-piperidino-5,5-dimethyl-4,5,6,7-tetrahydrobenzothiazol-7-one | 15091-02-8

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-piperidino-5,5-dimethyl-4,5,6,7-tetrahydrobenzothiazol-7-one
• 英文别名: 5,5-Dimethyl-2-piperidin-1-yl-5,6-dihydro-4H-benzothiazol-7-one；5,5-dimethyl-2-piperidin-1-yl-4,6-dihydro-1,3-benzothiazol-7-one
• CAS: 15091-02-8
• 化学式: C₁₄H₂₀N₂OS
• mdl: MFCD01815926
• 分子量: 264.392
• InChiKey: HSTYHTJKNPQSPN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.714
• 拓扑面积：
  61.4
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-氨基-5,5-二甲基-5,6-二氢-4H-苯并噻唑-7-酮 在 亚硝酸丁酯 、 copper dichloride 作用下， 以 异丙醇 、 乙腈 为溶剂， 反应 0.33h， 生成 2-piperidino-5,5-dimethyl-4,5,6,7-tetrahydrobenzothiazol-7-one
  参考文献：
  名称：

  Stepanov; Ivanov; Ivanova, Russian Journal of General Chemistry, 2000, vol. 70, # 5, p. 784 - 787

  摘要：

  DOI：

文献信息

• 4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase
  作者：Rikki Alexander、Ahrani Balasundaram、Mark Batchelor、Daniel Brookings、Karen Crépy、Tom Crabbe、Marie-France Deltent、Frank Driessens、Andrew Gill、Sue Harris、Gillian Hutchinson、Claire Kulisa、Mark Merriman、Prakash Mistry、Ted Parton、James Turner、Ian Whitcombe、Sara Wright

  DOI：10.1016/j.bmcl.2008.06.076

  日期：2008.8

  4-(1,3-Thiazol-2-yl)morpholine derivatives have been identified as potent and selective inhibitors of phosphoinositide 3-kinase. The SAR data of selected examples are presented and the in vivo pro. ling of compound 18 is shown to demonstrate the utility of this class of compounds in xenograft models of tumor growth. (c) 2008 Elsevier Ltd. All rights reserved.
• Role of PI3K p110 delta Signaling in Retroviral Infection and Replication
  申请人：Katsikis Peter D.

  公开号：US20110135655A1

  公开（公告）日：2011-06-09

  The invention includes compositions and methods for regulating PI3K p110 delta as an anti-retroviral therapy. The invention includes inhibiting p110 delta, a component of PI3K p110 delta signaling pathway, or any combination thereof in a cell as an anti-retroviral therapeutic approach for treating a retroviral infection, for example HIV. The invention includes a method of modulating PI3K p110 delta in a cell infected with a retrovirus by contacting the cell with an effective amount of a composition comprising an inhibitor of PI3K p110 delta.
• Compositions and Methods for Preventing or Treating Influenza Virus Infection
  申请人：Katsikis Peter D.

  公开号：US20120184519A1

  公开（公告）日：2012-07-19

  The invention includes compositions and methods for regulating PI3K p110 delta as an anti-retroviral therapy. The invention includes inhibiting p110 delta, a component of PI3K p110 delta signaling pathway, or any combination thereof in a cell as an anti-retroviral therapeutic approach for treating a retroviral infection, for example HIV. The invention includes a method of modulating PI3K p110 delta in a cell infected with a retrovirus by contacting the cell with an effective amount of a composition comprising an inhibitor of PI3K p110 delta.
• Role of PI3K P110 Delta Signaling in Retroviral Infection and Replication
  申请人：Katsikis Peter D.

  公开号：US20130116267A1

  公开（公告）日：2013-05-09

  The invention includes compositions and methods for regulating PI3K p110 delta as an anti-retroviral therapy. The invention includes a method of inhibiting p110 delta, a component of PI3K p110 delta signaling pathway, or any combination thereof in a cell as an anti-retroviral therapeutic approach for treating a retroviral infection, for example HTV. The invention includes a method of modulating PI3K p110 delta in a cell infected with a retrovirus by contacting the cell with an effective amount of a composition comprising an inhibitor of PI3K P110 delta.
• Stepanov; Ivanov; Ivanova, Russian Journal of General Chemistry, 2000, vol. 70, # 5, p. 784 - 787
  作者：Stepanov、Ivanov、Ivanova

  DOI：——

  日期：——